Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT02973035
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 104 participants
- Registry
-
NCT02973035
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02973035. Randomized; no masking; primary purpose treatment. Start 2016-12 (registry gives no type); primary completion 2020-01-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- Amlodipine
- Intervention (Drug)
- Valsartan
- Lead sponsor
- Asan Medical Center
- Collaborator
- Yuhan Corporation
Record details
- Record id
cardio:ct-nct02973035- Content hash
323e78d76773e91bc609021fe61be4eb0af572c1b3b82ee32309a01ee729a888